Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Vadim Sapiro, Nick Stiso, Judy Macemon, Richard Moore, Laura Lauman, Nikolaus Rajewsky

Premium

OpGen has appointed Vadim Sapiro to chief information officer, Nick Stiso to vice president of manufacturing operations, and Judy Macemon to vice president of marketing. The company has also promoted Richard Moore to chief scientific officer.

Sapiro will be responsible for developing OpGen's bioinformatics applications, software, databases, and information technology operations. He joins the company from SAIC-Frederick, where he was senior vice president overseeing the information systems program for the National Cancer Institute. Previously, he was vice president for information technology at the J. Craig Venter Institute. He holds a BS in mathematics and computer science from the University of Maryland.

Stiso will be responsible for all manufacturing operations of OpGen's Argus Whole Genome Mapping Systems consumables and reagents kits. Previously, he held executive-level positions in development and manufacturing operations at Biosite Diagnostics, Accumetrics, Syva, GeneOhm Sciences (now Becton Dickinson), and Miles Laboratories. He holds a BS in chemistry from Georgetown University and a PhD in physical chemistry from Michigan State University.

In her role as vice president of marketing, Macemon will be responsible for the company's product portfolio management commercial strategies and tactics. Before joining OpGen, she was vice president of marketing at Helixis (now Illumina), and held senior marketing roles at Life Technologies, Stratagene (now Agilent), MicroProbe, and Becton Dickinson. She holds a BS in medical technology from Louisiana State University, an MS in clinical microbiology from Texas Women's University, and an MBA from San Diego State University.

Moore was promoted to chief scientific officer at OpGen from vice president of diagnostic systems, a position he held since he joined the company in October 2008. In his new role, he will lead the R&D organization and will head up scientific collaborations with the genetics research, public health, and clinical research communities. He holds an MD and a PhD in cellular immunology from the University of Maryland, Baltimore, and a BS in chemical and nuclear engineering from the University of Maryland, College Park.


Illumina has hired Laura Lauman as vice president of marketing. Most recently, Lauman ran her own consulting business, advising executives in the life science and clean tech business. She also spent 15 years at Life Technologies/Applied Biosystems, where she was a division president and general manager of the proteomics and small molecule division. Additionally, she has held leadership roles at both PerkinElmer and Waters Associates. She holds a BS in biology from Boston College.


The Joint Committee of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) in Bonn has named 11 researchers as winners of the 2012 Leibniz Prize. Included is Nikolaus Rajewsky from the Max Delbrück Center for Molecular Medicine in Berlin.

His research combines theoretical and experimental methods to understand gene regulation, with a major focus on small RNAs. He employs multiple next-generation sequencers, including a recently installed Pacific Biosciences RS, as well as Illumina, 454, and SOLiD to do transcriptome sequencing, small RNA deep sequencing, and ChIP-seq.

He holds a PhD in theoretical physics from the University of Cologne.


Takashi Gojobori has joined the National Cheng Kung University in Taiwan, where he will lead genomics research at the university's Comparative Genomics Center. Gojobori joins the university from the National Institute of Genetics in Japan, where he serves as vice director and also as professor at the Center for Information Biology and DNA Data Bank of Japan.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.